Omada Health Inc（OMDA）财务数据OMDAOmada Health Inc

Evaluating the bottom line, Omada Health, Inc. maintains a gross margin of 70.20%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -4.45%, while the net margin is 6.56%. These profitability ratios, combined with a Return on Equity (ROE) of 1.84%, provide a clear picture of how effectively OMDA converts its operational activities into shareholder value.

In the context of the broader market, OMDA competes directly with industry leaders such as WBTN and ZH. With a market capitalization of $1.47B, it holds a leading position in the sector. When comparing efficiency, OMDA's gross margin of 70.20% stands against WBTN's 26.04% and ZH's 59.60%. Such benchmarking helps identify whether Omada Health, Inc. is trading at a premium or discount relative to its financial performance.

The company has shown significant revenue growth, with Q2 2026 revenue reaching $87.835 million, up from $78.048 million in Q1 2026. Gross margins are also strong, with a gross margin of 70.20% in Q2 2026, indicating efficient cost management.